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Pharmacologic effects of CI-581, a new 
dissociative anesthetic, in man 
Pharmacologic actions of CI-581, a chemical derivative of phencyclidine, were 
determined in 20 volunteers from a prison population. The results indicate that this drug is 
an effective analgesic and anesthetic agent in doses of 1.0 to 2.0 mg. per kilogram. With 
intravenous administration the onset of action is within 1 minute and the effects last for about 
5 to 10 minutes, depending on dosage level and individual variation. No tachyphylaxis was 
evident on repeat doses. Respiratory depression was slight and transient. Hypertension, 
tachycardia, and psychic changes are undesirable characteristics of the drug. Whether these 
can be modified by preanesthetic medication was not determined in this study. Recovery 
from analgesia and coma usually took place within 10 minutes, although from 
electroencephalographic evidence it may be assumed that subiects were not completely 
normal until after 1 to 2 hours. No evidence of liver 01' kidney toxicity was obtained. 
CI-581 produces pharmacologic effects similar to those reported for phencyclidine, but 
of shorter duration. The drug deserves further pharmacologic and clinical trials. It is 
proposed that the words "dissociative anesthetic" be used to describe the mental state 
produced by this drug. 
Edward F. Domino, M.D., Peter Chodoff, M.D., and Guenter Corssen, M.D. 
Ann Arbor, M ich. 
Departments of Pharmacology and Anesthesiology, The University of Michigan Medical Center 
The remarkable analgesic and anesthetic 
properties of phencyclidine have stimulated 
a search for derivatives that would offer 
the same benefits with less psychotomimetic 
effects. 3 Recent studies in laboratory ani-
mals by McCarthy and co-workers7 indi-
cate that such an agent might be found in 
CI-581, a chemical derivative of phencycli-
dine, with the formula, 2-( o-chlorophenyl)-
2-methylamino cyclohexanone HCI (Fig. 
1). CI-581 produced immobilization and/or 
general anesthesia in a variety of animals 
and in a broad range of dosages. Although 
this compound is less potent on a milligram 
per kilogram basis than phencyclidine, its 
central depressant action is significant with 
much less central excitatory effects. More-
over, CI-581 has a shorter duration of ac-
tion which should allow greater control-
ability in clinical use. 
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Fig. 1. Chemical structures of CI-581 and phen-
cyclidine. 
For these reasons a study was undertaken 
to determine the pharmacodynamic effects 
of CI-581 in human subjects. This article 
describes the results of this initial phase I 
investigation. 
Methods 
Male inmates of a prison volunteered as 
subjects. From this group, 20 were selected 
ranging from 25 to 48 years old, with a 
mean age of 37.4. Preliminary examinations 
ruled out any physical and mental aberra-
tions. During the week before the experi-
ment, and also one day and one week after-
ward, the following laboratory studies were 
carried out in all cases: hemoglobin and 
hematocrit determinations, erythrocyte and 
leukocyte counts, sedimentation rate, plate-
lets, SCOT, SCPT, alkaline phosphatase, 
blood urea nitrogen, sodium, potassium, 
chloride, and glucose (Table I). Routine 
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urinalyses were also performed; these in-
cluded color, appearance, specific gravity, 
albumin, sugar, pH, ketones, bile, red and 
white cell counts for both high- and low-
power field, and presence of casts. 
All subjects fasted at least 12 hours be-
fore the experimental drug was adminis-
tered. At the beginning of the experiment, 
the subject was placed supine and con-
nected to a polygraph for measuring vital 
signs. EEC recordings were made from F 3, 
C 3 , P 3, and 0 1 to both ears as reference 
(10-20 system6 ); EKC was recorded from 
lead n, and respiration monitored by tho-
racic and abdominal rubber cuffs, or a 
Fleisch pneumotachograph which gave an 
accurate measure of respiratory rate and 
also tidal voJume changes measured as the 
area under the curve with a Celman 
planimeter. Arterial blood pressure was 
monitored by the inflatable cuff method or 
intra-arterial recordings by a Statham pres-
sure transducer. In addition, arterial p02 
and venous blood sugar determinations 
were made. 
The drug, CI-581, was administered in-
travenously into the tubing of a saline in-
fusion over a one minute period, in doses 
ranging from 0.1 to 2.0 mg. per kilogram 
body weight. Each subject received the 
drug on two different days, with an interval 
of at least a week. The effects of CI-581 
Table I. Means and ranges of laboratory data before and after CI-581 given to 18 subjects 
Hemoglobin Hematocrit RBC's WBC's ESR Platelets 
Pretreatment 
Mean 14.6 44 5.11 8.0 6 280 
Range 13.1-15.5 41-46 4.54-5.51 5.0-11.8 1-9 200-417 
Posttreatment (24 to 72 hours) 
Mean 15.3 47 5.30 9.1 6 239 
Range 14.1-16.8 43-51 4.92-5.76 5.5-13.3 1-10 215-280 
Posttreatment (day 7) 
Mean 14.8 45 5.21 9.1 7 
Range 13.8-15.7 41-48 4.82-5.55 5.5-15.1 2-16 
After second treatment (7 days) 
Mean 14.8 45 5.18 8.6 7 
Range 12.7-16.6 40-50 4.39-5.89 4.6-12.7 1-13 
Volume 6 
Number 3 
PharmacologiC effects of a phencyclidine derivative 281 
on somesthetic and visual input into the 
cerebral cortex were studied by means of 
computer techniques described previous-
ly/-5 and the data were analyzed according 
to Snedecor.8 
Results 
Analgesic and anesthetic effects. The ef-
fect of CI-581 on pain sensation was tested 
by crushing the skin over the subject's chest 
or arms with a hemostat. Loss of conscious-
ness was gauged by constant quizzing of 
the subject, and the end point of coma was 
taken as the time the subject could re-
establish verbal communication with the in-
vestigators, even though his responses were 
far from normal at this time. 
Fig. 2 illustrates the effects of increasing 
doses of Cl -581 on duration of coma, the 
scatter of points indicating the variability. 
At doses of 0.1 mg. per kilogram, no sig-
nificant alteration in level of consciousness 
was noted, and at 0.5 mg. per kilogram only 
half the subjects showed loss of conscious-
ness. In doses of 1.0 mg. per kilogram, the 
duration of coma ranged from 3 to 10 min-
utes, with a mean of 5.7. With 1.5 mg. per 
kilogram the mean duration was 9.1 min-
utes and at 2.0 mg. per kilogram it was 10 
minutes. 
The syndrome immediately following the 
administration of the drug was of interest. 
Alkaline Thymol 
SCOT SCPT phosphatase turbidity BUN 
14 12 7.8 2.8 14 
8-25 5-34 5.0-10.3 0.5-6.8 9-17 
16 14 8.8 3.1 13 
8-28 5-38 5.4-13.7 0.3-8.8 9-20 
16 13 8.9 2.8 13 
10-33 4-39 5.2-13.9 0.5-6.9 8-20 
18 15 9.0 3.3 13 
11-45 5-53 5.9-13.2 1.1-9.7 8-22 
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Fig. 2. Effects of increasing doses of Cl-581 on 
duration of coma. 
Usually the subject was asked to keep his 
eyes closed during the procedure. Within a 
minute after drug injection, the subject re-
ported numbness of the entire body, al-
though sensation to touch remained intact. 
After 1.0 mg. per kilogram or more of CI-
581, the subject would open his eyes and 
at the same time lose contact with thc en-
vironment. Both corneal and wink reflexes 
were brisk at this time, and marked nystag-
Bile Na K Cl BSP 
0.4 145 4.6 109 4 
0.3-0.7 140-148 4.1-5.2 106-112 2-9 
0.4 146 5.0 107 
0.1-0.6 143-149 4.2-5.7 100-112 
0.4 144 4.8 107 
0.1-1.0 141-148 4.1-5.6 100-114 
0.4 146 4.8 107 5 
0.2-0.7 141-149 4.2-5.4 101-112 3-9 
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mus was noted. Complete analgesia was 
evidenced by the lack of reaction to various 
pain-inducing procedures. Many subjects 
showed marked lacrimation and profuse 
sweating. The patellar, Achilles, and "H" 
reflexes were hyperactive. During the ini-
tial phase of coma, respiration was slightly 
depressed, although respiratory assistance 
was not needed. In some instances, how-
ever, manual support of the chin was re-
quired to maintain a patent airway. Some 
subjects clenched their jaws tightly, as if 
holding something in their teeth. Skeletal 
muscle tone appeared to be increased in the 
neck and extremities; tendon reflexes were 
hyperactive. Closing the eyes usually her-
alded return to consciousness, and shortly 
thereafter the subject responded to ques-
tions. Difficulty in speaking, as well as evi-
dence of analgesia, continued for a few 
minutes after verbal contact was re-estab-
lished. 
During the recovery period the subjects 
showed considerable variability in psychic 
reaction. Some were completely oriented 
in time and place and showed no signifi-
cant changes. Others showed marked alter-
ation in mood and affect, some becoming 
apprehensive and aggressive and others 
markedly withdrawn. Almost all the sub-
jects felt entirely numb, and in extreme 
instances stated that they had no arms or 
legs, or that they were dead. If they were 
touched, however, or moved, such stimuli 
were perceived. Neurologically all subjects 
showed rotatory nystagmus and ataxia. 
Diminution of visual acuity was marked. 
Other reactions noted included feelings of 
estrangement or isolation, negativism, hos-
tility, apathy, drowsiness, inebriation, hyp-
nogenic states, and repetitive motor be-
havior. 
At times some of the subjects had vivid 
dreamlike experiences or frank hallucina-
tions. Some of these involved the recall of 
television programs or motion pictures seen 
a few days before, or they were at home 
with their relatives, or were in outer 
space, and so on. Some of these phenom-
ena were so real that the subjects could 
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not be certain they had not actually 
occurred. 
Usually these psychological aberrations 
subsided completely within a half hour af-
ter awakening. The subjects gradually be-
came well oriented and frequently ex-
pressed amazement at the experience; most 
found the experience pleasant and were 
willing to undergo a second experiment, 
although 2 refused to continue. Usually the 
subjects appeared completely normal with-
in 1 to 2 hours, playing cards or pool, or 
otherwise engaging in the activities around 
them. 
It was of interest to determine whether 
immediate repetition of another dose of 
CI-581 would produce anesthesia and anal-
gesia. Accordingly, 10 subjects who had 
been given an initial dose of 1 mg. per 
kilogram were given the same dose a sec-
ond time immediately after the initial 
coma had ended. In this series the coma 
had lasted 3 to 8 minutes, with a mean 
duration of 6. After the second dose, the 
periods of coma ranged from 5 to 12 min-
utes, with a mean duration of 8 (Fig. 3). 
It was concluded that repeated doses of 
CI-581 cause a slight increase in the dura-
tion of coma. No evidence of tolerance was 
noted under these conditions. 
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Fig. 3. Effects of a repeated dose of CI-58l on 
mean duration of coma. 
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The most dramatic Rnding in this aspect 
of the study was the marked degree of anal-
gesia without coma which could be induced 
by CI-58l. This was demonstrated dra-
matically when the drug was given as a 
continuous intravenous infusion, accom-
plished by administering a total of 100 mg. 
of Cl-58l in 100 m!. of saline. At approxi-
mately 125 to 180 drops per minute, the 
subject showed profound analgesia with-
out loss of consciousness far about 10 min-
utes. During this period he responded to 
questions though speech was slurred. Al-
though the subject was conscious, he felt 
absolutely no pain to severe pinching with 
a hemostat. 
Cardiovascular effects. Cl-58l praduced 
increases in arterial blood pressure in hu-
man subjects, as it did in earlier studies in-
volving dogs and monkeys. 7 The cardio-
vascular changes were observed at dosage 
levels which were not necessarily associated 
with coma. Fig. 4 illustrates the effects of 
increasing dases of Cl-58l in terms of mean 
change over the control level in blood pres-
sure and heart rate. Also shown are the 
effects of saline injection given to the sub-
ject as though it were active drug; slight 
increases in heart rate and blood pressure 
were noted under these conditions. Al-
though doses of 0.1 mg. per kilogram did 
not produce coma, they did cause bload 
pressure increases of about 25 mm. Hg 
systolic and 16 mm. Hg diastolic, as well 
as a slight increase in heart rate. The mean 
blaod pressure values increased with larger 
doses of CI-58l; in heart rate, however, 
the greatest increase was noted at dases of 
0.5 mg. per kilogram of Cl-58l; larger doses 
did not induce any further change. The 
elevated diastolic pressures probably indi-
cated increased peripheral resistance. 
Fig. 5 shows the mean per cent increase 
over control levels of systolic and diastolic 
blood pressures at various dosage levels. 
These data are similar to thase in Fig. 4. 
The maximum increases were nated within 
5 minutes after drug administratian. The 
return to preinjectian levels did nat co-
incide with recovery from coma. About 10 
to' 20 minutes after partial recavery, at a 
time when the subject clearly was in can-
tact with the environment, the arterial 
blaod pressure was still slightly elevated 
over control levels, and it did nat return 
to narmal until after about one hour. 
The effects of a second dase of CI-58l 
were observed in 10 subjects. A few min-
utes after the initial dose af 1 mg. per kila-
gram of Cl-58l, increases in both systolic 
and diastolic blaad pressures were noted, 
as illustrated in the cantrol bar graph in 
Fig. 6. When cantact was reestablished for 
each subject, about 10 minutes after drug 
administratian, the blood pressures were 
still somewhat elevated. A second dase of 
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Fig. 6. Effects of a repeat dose of CI-58l on mean 
arterial blood pressure. 
1 mg. per kilogram of Cl -581 given at this 
time again produced anesthesia and in-
creased blood pressure, which reached 
about the same levels as noted during the 
peak action of the first dose. 
Respiratory effects. In anesthetic doses, 
CI-581 produced transient respiratory de-
pression. Most of the subjects did not need 
assistance in maintaining a patent airway. 
Several objective measures of vital signs 
were obtained, as indicated in Fig. 7. The 
Simplest of these included the recording of 
thoracic and abdominal respiration by 
means of rubber cuffs connected to suitable 
strain gauges and the polygraph. Frequent-
ly both the thoracic and the abdominal 
ventilatian was altered, but it was obviaus 
that respiratory rate was much less affected 
than tidal valume. As can be seen, respira-
tory rate was maximally depressed, 1 or 2 
minutes after drug injection, from mean 
rates of abaut 18 to about 10. Return to 
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preinjection values took place gradually 
over the next 3 to 5 minutes. To rule out 
passible mechanical abstruction, intuba-
tion was carried aut in 2 subjects fallowing 
intratracheal instillatian of 5 ml. of 2 per 
cent lidocaine. The endotracheal tube was 
attached to a Fleisch pneumatachagraph. 
A transient but often marked decrease in 
ventilation was observed 1 or 2 minutes 
after drug injectian, the tidal volume de-
creasing more than the rate. Similar find-
ings were noted in 4 ather subjects who 
breathed through the Fleisch pneumotach-
ograph without intubation. 
As another index of respiratory function, 
the Waters ear oximeter was used for a 
palygraph record of the relative per cent 
arterial axygen saturatian. Since ear axim-
etry yields qualitative rather than quanti-
tative values, the arterial p02 also was 
determined in 2 subjects by means of an 
arterial catheter placed, under local anes-
thesia, in the brachial artery at the level of 
the antecubital fossa. 
All af these vital signs were recarded 
before and after the administration of twO' 
doses af Cl-581, 1 mg. per kilogram each, 
given 5 minutes apart. Fig. 8 shaws the 
changes follOWing the administration af the 
drug in one subject. The first injection pro-
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duced increases in systolic and diastolic 
pressures and decreases in respiratory rate 
and arterial oxygen saturation with the 
values returning gradually to control levels. 
The effects of the second injection were 
similar to those of the first. 
Electroencephalographic effects. Doses 
of 0.5 to 2.0 mg. per kilogram of CI-581 
given intravenously produced consistent 
and marked changes in the EEG in all sub-
jects. During saline infusion, with the sub-
ject resting comfortably and his eyes closed, 
alpha rhythm was recorded in the parietal 
and occipital areas in most instances. From 
the tracing in upper left-hand panel of Fig. 
9, it can be seen that alpha discharge was 
recorded predominantly in 0 1 to both ears 
as reference. Alphalike waves were also 
recorded from Ps, C 3 , and to a lesser extent 
from F 3. Characteristic thetalike waves 
were recorded at dosage levels which pro-
duced coma; these were distributed over 
most of the cerebral hemisphere. Typical 
thetalike rhythm is shown in upper right-
hand panel of Fig. 9, 6 minutes after the 
administration of 1.5 mg. per kilogram of 
CI-581, when the subject was unresponsive. 
It can be seen that this activity was present 
in all leads but most prominently in P3 • 
About lO minutes after drug injection, the 
subject regained consciousness and the 
theta rhythm was replaced by typical low-
voltage, fast frequency activity. Complete 
analgesia was still present although the 
subject was awake and communicating with 
the investigators. After analgesia disap-
peared and the subject was in full contact 
with his environment, there still were no 
alpha waves. This rhythm was not re-
established until at least a half to one hour 
after drug injection. 1lle lower right-hand 
panel in Fig. 9 shows the partial return 
of alpha rhythm 42 minutes following drug 
injection. 
The abolishing of the alpha waves and 
induction of theta activity were the most 
consistent and typical EEG effects of CI-
581. During the period of coma as well as 
the recovery phase of some patients, in-
creased skeletal muscle activity was re-
corded, which correlated with the marked 
increase in tone often noted in the masseter 
and temporal muscles. Delta activity that 
is characteristic of many inhalation anes-
thetics was recorded in only a few in-
stances. Also absent were the burst-sup-
pression patterns or EEG fast waves typical 
of barbiturates and other sedative-hypnot-
ics. 
Effects on visually evoked responses. 
The effects of Cl -581 on visually evoked 
responses (VER) were observed in 6 sub-
jects. At doses which produced coma, de-
pression of the primary complex of the 
VER and enhancement of a portion of the 
secondary complex were observed, as pre-
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viously reported with other substances 
which promote sleep or loss of conscious-
ness. 2 , 4 In addition, the rhythmic afterdis-
charge following the light flash was abol-
ished. These observations were in keeping 
with the disappearance of alpha rhythm 
from the EEG patterns. Fig. 10 illustrates 
the VER changes in one subject. During 
the saline infusion a typical response was 
obtained by light directed into the sub-
ject's eyes at a flash rate of 1 per second. 
The arrows in Fig. 10 indicate the light 
stimulus which is followed by the sum-
mated VER for 500 msec. With the sub-
ject's eyes closed, a reproducible series of 
electrical waves can be recorded. This is 
followed by a rhythmic afterdischarge with 
a frequency similar to alpha rhythm. CI-581 
in a dose of 2.0 mg. per kilogram altered 
the VER as illustrated. The evoked po-
tentials gradually returned toward control 
levels after the patient recovered from 
coma. 
Effects on somesthetic responses. The 
effect on somesthetic input was of partic-
ular interest in view of this drug's ability, 
in the awakening patient, to produce sub-
jective numbness without blocking touch 
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sensation. The summated cerebral somes-
thetic responses were determined by stimu-
lation of the contralateral medial nerve. 
Somesthetic responses elicited at three 
times the sensory threshold were recorded 
before the injection, at the height of coma, 
and during recovery. For recording the 
short latency component, an analysis time 
of 125 msec. was used; for long latency 
components, 500 msec. At doses ranging 
from 0.5 to 2.0 mg. per kilogram, enhance-
ment of the initial components of the som-
esthetic response was recorded which per-
sisted throughout coma (Fig. 11). It is 
noteworthy that at the time the subject 
complained of numbness and yet could feel 
stimuli to the contralateral wrist, the evoked 
response was obtained from the "hand area" 
in the brain. Although the short latency re-
sponses were clearly present, the much 
longer latency responses beyond 90 msec. 
were reduced. Usually these responses did 
not return to control levels until Ij2 to 2 
hours after drug administration. 
Laboratory studies. The effects of CI-581 
on liver and kidney function, electrolytes, 
and blood counts were determined the day 
before drug injection and also 3 and 7 days 
O.-R 
DRUG TREATMENT 
0.9" SALINE ~ ~ 
CI-581 
2 mg/kg, I.V. 
~IO;UV 
100 m sec. 
~3min.coma 
 10 min. Coma 
t\!'-- 23min.Awoke 
Pt. R.e. 
Fig. 10. Effects of CI-581 on visually evoked n'spome. 
Volume 6 
Number 3 
PharmacologiC effects of a phencyclidine derivative 289 
DRUG TREATMENT 
as" SALINE 
CI-581 
2 mg/kg, 1.11. 
3 min. Coma 
8 min. Contact 
18 min. Awoke 
~2.5}LV 
25m sec. 
Pt. R.C. 
Fig. 11. Effects of CI-581 on somesthetieally evoked response. 
afterward. As indicated in Table I, these 
values were not significantly affected by 
the drug. 
Discussion 
The studies demonstrate that CI-581 ex-
erts pharmacologic actions in man which 
are similar to those reported for laboratory 
animals. 7 CI-581 is less potent and shorter 
acting than the parent drug, phencyclidine, 
but otherwise quite similar. At equivalent 
analgesic dosages, CI-581 is about one-
fourth as potent as phencyclidine; how-
ever, in degree of analgesia and coma, the 
two drugs are about equal, so that CI-581 
appears to be as effective as phencyclidine 
in the induction of analgesia and anesthesia. 
No convulsions were noted in our sub-
jects, with a fourfold increase in dosage of 
Cl -581. This finding seems to be in contrast 
with that reported for phencyclidine. Also 
the shorter duration of action of Cl -581 
should be a distinct advantage in cases 
where brief analgesia and anesthesia are 
required. Minute-to-minute control may be 
achieved by additional doses or by an in-
fusion technique. 
The principal disadvantage of phencycli-
dine is its adverse psychic effects. In our 
studies CI-581 produced very similar quali-
tative alterations; quantitatively, however, 
these reactions were conSiderably shorter 
in duration than those reported for phency-
clidine. Some of the changes apparently 
represent a primary pharmacologic action 
of this class of compounds. Most of the sub-
jects showed changes in mood, body image, 
and affect, and some reported vivid dreams 
and/or hallucinations. In some cases the 
subjects found the experience frightening 
and described it as like death or like being 
in outer space. It is of considerable im-
portance, however, that the psychic altera-
tions induced by CI-581 were short lasting, 
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and that some of the subjects experienced 
no undesirable effects at all. 
Whether the incidence of pathologic 
mental changes may limit the clinical use-
fulness of CI-581 needs to be evaluated 
further. It should be emphasized that the 
volunteers purposely received no preanes-
thetic medication. The possible effects of 
premedicants on the psychic state, as well 
as coma, analgesia, and blood pressure, are 
yet to be clarified. The basic pharmacologic 
experiments obviously must be supple-
mented by studies of the drug under actual 
clinical conditions. Such studies are now in 
progress. 
One of the most remarkable features of 
Cl -581 is its ability to produce profound 
analgesia. With this drug as the sole anal-
gesic and anesthetic agent, it is possible to 
carry out painful operative procedures of 
short duration (Corssen and Domino, to 
be published). In coma-producing doses, 
CI-581 causes transient dose-related respi-
ratory depression that is not clinicaly sig-
nificant. 
The cardiovascular actions of CI-581 fol-
low a predictable pattern. The drug con-
sistently produces an increase in systolic 
and diastolic blood pressure as well as 
tachycardia. In some subjects the transient 
hypertension was alarming, while in others 
it was barely perceptible. These cardio-
vascular changes, combined with frequent 
sweating, lacrimation, and hyperactive ten-
don reflexes, have led Chen and his as-
sociates
' 
to suggest that phencyclidine and 
its derivatives are sympathomimetic. Blood 
glucose levels tend to rise after CI-581, al-
though not to the degree that might be ex-
pected with equal pressor doses of epi-
nephrine. Moreover, the increase in dias-
tolic pressure following CI-581 would rule 
out epinephrine release as the sole mecha-
nism for the induced hypertension. In-
creases in blood pressure can take place 
with doses of Cl -581 that do not produce 
coma; where coma is produced, hyperten-
sion usually outlasts the period of anes-
thesia. 
In conclusion, these first human phar-
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macologic studies of CI-581 indicate that 
intravenous administration of the drug can 
produce profound analgesia and short-last-
ing anesthesia. The powerful analgesic 
action is of special interest. Respiratory 
depression is transient and not a serious 
problem. Many protective reflexes such as 
laryngeal, pharyngeal, eyelid, and corneal 
are present during the patient's unrespon-
siveness. No liver, kidney, or blood ab-
normalities or venous irritation were noted 
in the subjects tested. Undesirable pharma-
cologic effects include marked sympathomi-
metic activity resulting in hypertension and 
tachycardia, as well as psychotic changes 
resembling those seen with phencyclidinea 
but of much shorter duration. The possible 
clinical usefulness of CI-581 as a short-
acting intravenous anesthetic needs to be 
studied and probably will depend on 
whether these undesirable effects can be 
suppressed by preanesthetic medication. 
The unusual analgesic and anesthetic ac-
tion of this drug with sympathomimetic 
properties, and cerebral dissociative actions, 
makes it imperative that a new terminology 
be developed for drugs of this type. It is 
suggested that the state produced by this 
drug be called "dissociative" anesthesia. 
We would like to thank Dr. A. Lane and Dr. 
E. L. Holmes for making available the facilities of 
the Parke, Davis Clinical Unit at the State Prison 
of Southern Michigan at Jackson, and Dr. C. E. 
Moyer of the Clinical Laboratory of Parke, Davis 
for the laboratory studies. 
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